These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 36454715)

  • 1. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.
    Russo AF; Hay DL
    Physiol Rev; 2023 Apr; 103(2):1565-1644. PubMed ID: 36454715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene-related peptide and beyond.
    Garelja ML; Hay DL
    Headache; 2022 Oct; 62(9):1093-1104. PubMed ID: 36226379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of the Potential Receptors of Migraine with a Special Emphasis on CGRP to Develop an Ideal Antimigraine Drug.
    Naduchamy KP; Parthasarathy V
    Curr Mol Pharmacol; 2021; 14(1):11-26. PubMed ID: 32838728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGRP receptor antagonism and migraine therapy.
    Edvinsson L; Warfvinge K
    Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain pharmacology in migraine: focus on CGRP and CGRP receptors.
    Benemei S; Nicoletti P; Capone JA; Geppetti P
    Neurol Sci; 2007 May; 28 Suppl 2():S89-93. PubMed ID: 17508187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
    Hargreaves R; Olesen J
    Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Holland PR; Saengjaroentham C; Vila-Pueyo M
    Cephalalgia; 2019 Mar; 39(3):390-402. PubMed ID: 29411638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin gene-related peptide (CGRP): a new target for migraine.
    Russo AF
    Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGRP receptor antagonists for migraine. Are they also AMY
    Garelja ML; Walker CS; Hay DL
    Br J Pharmacol; 2022 Feb; 179(3):454-459. PubMed ID: 34076887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular studies of CGRP and the CGRP family of peptides in the central nervous system.
    Hendrikse ER; Bower RL; Hay DL; Walker CS
    Cephalalgia; 2019 Mar; 39(3):403-419. PubMed ID: 29566540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcitonin gene-related peptide: a key player neuropeptide in migraine].
    Ramos-Romero ML; Sobrino-Mejia FE
    Rev Neurol; 2016 Nov; 63(10):460-468. PubMed ID: 27819404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGRP receptor antagonists: toward a novel migraine therapy.
    Salvatore CA; Kane SA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1671-80. PubMed ID: 21466447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
    Edvinsson L
    Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors.
    Garelja ML; Alexander TI; Bennie A; Nimick M; Petersen J; Walker CS; Hay DL
    Br J Pharmacol; 2024 Jan; 181(1):142-161. PubMed ID: 37580864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting CGRP: A New Era for Migraine Treatment.
    Wrobel Goldberg S; Silberstein SD
    CNS Drugs; 2015 Jun; 29(6):443-52. PubMed ID: 26138383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
    Haanes KA; Edvinsson L
    CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
    Durham PL; Vause CV
    CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
    Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
    J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.